Once-Daily Extended-Release Levetiracetam as Adjunctive Treatment of Partial-Onset Seizures in Patients with Epilepsy: A Double-Blind, Randomized, Placebo-Controlled Trial
Epilepsia 49:1-9, Peltola,J.,et al, 2008
Comparison of Levetiracetam and Controlled-Release Carbamazepine in Newly Diagnosed Epilepsy
Neurol 68:402-408, Brodie,M.J.,et al, 2007
Comparison of Levetiracetam and Controlled-Release Carbamazepine in Newly Diagnosed Epilepsy
Neurol 68:402-408, Brodie,M.J.,et al, 2007
Rapidly Progressive Dementia in a Man With HIV Infection and Undetectable Plasma Viral Load
Neurol 100:344-348, Chishimba,L.C.,et al, 2023
Tirofiban for Stroke without Large or Medium-Sized Vessel Occlusion
NEJM 388:2025-2095, Zi,W.,et al, 2023
Confused About Confusion
NEJM 386:80-87, Spanjaart, A.M.,et al, 2022
Initial Management of Seizure in Adults
NEJM 385:251-263, Smith, P.E.M., 2021
Levetiracetam in Management of Bilateral Trigeminal Neuralgia Due to Large Glomus Tumor Case Report
Cephalgia 4:1-4, Hsieh, B.,et al, 2021
Choosing Anticonvulsant Medications to Manage Status Epilepticus
NEJM 382:2569-2572, Wu, K., 2020
Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus
NEJM 381:2103-2113,2171, Kapur, J.,et al, 2019
Persistent Postural-Perceptual Dizziness (PPPD): A Common, Characteristic and Treatable Cause of Chronic Dizziness
Pract Neurol 18:5-13, Popkirov, S.,et al, 2018
Progressive Gait Difficulty and Incontinence in a 40-year-old Man with HIV
Neurol 91:1065-1070, Silverman, A.,et al, 2018
Disturbances of Cerebrospinal Fluid, Including Hydrocephalus, Pseudotumor Cerebri, and Low-Pressure Syndromes, Normal Pressure Hydrocephalus
Adams & Victors Principles of Neurology, Chp 30, pg 624, Ropper, A.H.,et al, 2014
Intracranial Neoplasms and Paraneoplastic Disorders, Gliomatosis Cerebri
Adams & Victors Principles of Neurology, Chp 31, pg 654, Ropper, A.H.,et al, 2014
Degenerative Diseases of the Nervous System, Parkinson Disease
Adams & Victors Principles of Neurology, Chp 39, pg 1082, Ropper, A.H.,et al, 2014
Results of Phase 2 Safety and Feasibility Study of Treatment with Levetiracetam for Prevention of Posttraumatic Epilepsy
Arch Neurol 69:1290-1295, Klein, P.,et al, 2012
Extended-Release Pramipexole in Advanced Parkinson Disease
Neurol 77:767-774, Schapira, A.H.V.,et al, 2011
Comparative Effectiveness of 10 Antiepileptic Drugs in Older Adults With Epilepsy
Arch Neurol 67:408-415, Arif,H., et al, 2010
Clinicopath Conf, Neuro-Behcets Disease
NEJM 360:2341-2351, Case 17-2009, 2009
Anti-N-Methyl-D-Aspartate Receptor (NHMDAR) Encephalitis in Children and Adolescents
Ann Neurol 66:11-18,1, Florance,N.R.,et al, 2009
Response of Infantile Spasms to Levetiracetam
Neurol 70:574-575, Mikati,M.A.,et al, 2008
Antiplatelet Therapy in Aneurysmal Subarachnoid Hemorrhage
Stroke 39:2186-2187, Dorhout Mees,S.M.,et al, 2008
A 63-Year-Old Man With Headaches and Behavioral Deterioration
Neurol 68:782-787, Greenberg,S.M.,et al, 2007
Placebo-Controlled Study of Levetiracetam in Idiopathic Generalized Epilepsy
Neurol 69:1751-1760,1734, Berkovic,S.F.,et al, 2007
Ropinirole 24-Hour Prolonged Release: Randomized, Controlled Study in Advanced Parkinson Disease
Neurol 68:1108-1115, Pahwa,R.,et al, 2007
Levetiracetam for Seizures After Liver Transplantation
Neurol 64:1084-1085, Glass,G.A., et al, 2005
Use of Levetiracetam to Treat Tics in Chidlren and Adolescents With Tourette Syndrome
Movement Disorders 20:714-718, Awaad,Y.,et al, 2005
The New Antiepileptic Drugs, Scientific Review
JAMA 291:605-614, LaRoche,S.M.&Helmers,S.L., 2004
Levetiracetam in the Treatment of Idiopathic Hemifacial Spasm
Neurol 62:2134-2135, Deleu,D., 2004
Improvement of a Patient with a Stuttering on Levetiracetam
Neurol 59:1288, Canevini,M.P.,et al, 2002
The Catechol-O-Methyltransferase (COMT) Inhibitor Entacapone Enhances the Pharmacokinetic and Clinical Response to Sinemet CR in Parkinson's Disease
JNNP 68:589-594, Piccinni,P.,et al, 2000
Levetiracetam for Partial Seizures: Results of A Double-Blind, Randomized Clinical Trial
Neurol 55:236-242, Cereghino,J.J. et al, 2000
A Controlled Study of Additional sr-L-dopa in L-dopa-responsive Restless Legs Syndrome with Late-Night Symptoms
Neurol 52:285-290, Collado-Seidel,V.,et al, 1999
Clinicopath Conf,Wegener's Granulomatosis with Pachymeningeal Granulomatous Inflammation, Case 9-1999
NEJM 340:945-953, , 1999
Physician Assistants in Neurology Practice
Neurol 52:1513, Taft,J.M.&Hooker,R.S., 1999
Immediate-Release and Controlled-Release Carbidopa/Levodopa in PD, A 5-Year Randomized Multicenter Study
Neurol 53:1012-1019, Koller,W.C.,et al, 1999
Stereotactic pallidotomy for Trtm of Parkinson's Disease, Efficacy & Adverse Effects at 6 Mo in 26 Pts
Neurol 50:434-438, Shannon,K.M.,et al, 1998
Neuropsychological Consequences of Posteroventral Pallidotomy for the Treatment of Parkinson's Disease
Neurol 51:207-215, Trepanier,L.L.,et al, 1998
Six-Month Evaluation of Carbatrol (Extended-Release Carbamazepine) in Complex Partial Seizures
Neurol 519:1727-1729, Mirza,W.U.,et al, 1998
Drug Treatment of Parkinson's Disease
BMJ 310:575-579, Quinn,N., 1995
Radiologic-Clinical Correlation:Hemiballismus
AJNR 15:1377-1382, Provenzale,J.M.&Schwarzschild,M.A., 1994
Dopaminergic Treatment of Restless Legs and Rebound Phenomenon
Neurol 43:455, Guilleminault,C.,et al, 1993
Erythromelalgia:Review of Clinical Characteristics and Pathophysiology
Am J Med 91:416-422, Jurzrock,R.&Cohen,P.R., 1991
A Multi-Center, Double-Blind Study on Slow-Release Bromocriptine in the Treatment of Parkinson's Disease
Neurol 41:1598-1602, Mannen,T.,et al, 1991
A Comparison of Effects of Controlled-Release Levodopa (Madopar CR) with Levodopa in Late Parkinson's Disease
JNNP 53:220-223, MacMahon,D.G.,et al, 1990
A Double-Blind Crossover Comparison of Sinemet CR4 and Standard Sinemet 25/100 in Patients with Parkinson's Disease
JNNP 52:207-212, Cedarbaum,J.M.,et al, 1989
Efficacy of Sinemet CR4 in Subgroups of Patients with Parkinson's Disease
JNNP 52:83-88, Factor,S.A.,et al, 1989
The Acquired Immunodeficiency Syndrome (AIDS) Dementia Complex
Ann Int Med 111:400-410, Ho,D.D.,et al, 1989
Antiplatelet Therapy
NEJM 298:1403, Koch,J., 1978